Correlation Between MedMira and NervGen Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MedMira and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedMira and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MedMira and NervGen Pharma Corp, you can compare the effects of market volatilities on MedMira and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedMira with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedMira and NervGen Pharma.

Diversification Opportunities for MedMira and NervGen Pharma

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between MedMira and NervGen is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding MedMira and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and MedMira is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedMira are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of MedMira i.e., MedMira and NervGen Pharma go up and down completely randomly.

Pair Corralation between MedMira and NervGen Pharma

Assuming the 90 days horizon MedMira is expected to generate 15.3 times more return on investment than NervGen Pharma. However, MedMira is 15.3 times more volatile than NervGen Pharma Corp. It trades about 0.1 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about 0.05 per unit of risk. If you would invest  6.50  in MedMira on August 29, 2024 and sell it today you would lose (0.76) from holding MedMira or give up 11.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

MedMira  vs.  NervGen Pharma Corp

 Performance 
       Timeline  
MedMira 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MedMira are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, MedMira reported solid returns over the last few months and may actually be approaching a breakup point.
NervGen Pharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NervGen Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, NervGen Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

MedMira and NervGen Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MedMira and NervGen Pharma

The main advantage of trading using opposite MedMira and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedMira position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.
The idea behind MedMira and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope